Boris Waldman

HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes

Boris Waldman, Alicia J. Jenkins, Timothy M. E. Davis et al. · Diabetes Care · 2014 · 70 citations

Medicine, Endocrinology, Pharmacology +17

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Boris Waldman, Jean-Claude Ansquer, David Sullivan et al. · The Lancet Diabetes & Endocrinology · 2018 · 58 citations

Medicine, Endocrinology, Pharmacology +13

Epidemiological data of type 1 diabetes mellitus in children in Uzbekistan, 1998-2014

Gulnara Rakhimova, Nasiba Alimova, Alexsandr Ryaboshtan et al. · Pediatric Diabetes · 2017 · 16 citations

Medicine, Endocrinology, Pediatrics +15

Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD Study

Kwok Leung Ong, Rachel O’Connell, Andrzej S. Januszewski et al. · Clinical Chemistry · 2017 · 16 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Uric acid predicts <scp>long‐term</scp> cardiovascular risk in type 2 diabetes but does not mediate the benefits of fenofibrate: The <scp>FIELD</scp> study

Jacob Cao, Boris Waldman, Rachel O’Connell et al. · Diabetes Obesity and Metabolism · 2020 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17